PL1830850T3 - Pochodne chinoliny do leczenia gruźlicy utajonej - Google Patents

Pochodne chinoliny do leczenia gruźlicy utajonej

Info

Publication number: PL1830850T3
Authority: PL; Poland
Prior art keywords: treatment; quinoline derivatives; latent tuberculosis; tuberculosis; latent
Prior art date: 2004-12-24

Application number

PL05815816T

Other languages

English (en)

Inventor

Koenraad Jozef Lodewijk Marcel Andries

Anil Koul

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-24

Filing date

2005-12-08

Publication date

2011-07-29

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35717702&utm_source=***_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=PL1830850(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-12-08 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2011-07-29 Publication of PL1830850T3 publication Critical patent/PL1830850T3/pl

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Organic Chemistry (AREA)
Pulmonology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

PL05815816T 2004-12-24 2005-12-08 Pochodne chinoliny do leczenia gruźlicy utajonej PL1830850T3 (pl)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
EP04078529		2004-12-24
EP05105008		2005-06-08
PCT/EP2005/056594 WO2006067048A1 (en)	2004-12-24	2005-12-08	Quinoline derivatives for the treatment of latent tuberculosis
EP05815816A EP1830850B1 (en)	2004-12-24	2005-12-08	Quinoline derivatives for the treatment of latent tuberculosis

Publications (1)

Publication Number	Publication Date
PL1830850T3 true PL1830850T3 (pl)	2011-07-29

Family

ID=35717702

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL05815816T PL1830850T3 (pl)	2004-12-24	2005-12-08	Pochodne chinoliny do leczenia gruźlicy utajonej

Country Status (31)

Country	Link
US (1)	US20060142279A1 (pl)
EP (1)	EP1830850B1 (pl)
CN (1)	CN103142595B (pl)
AP (1)	AP2327A (pl)
AR (1)	AR051790A1 (pl)
AT (1)	ATE501721T1 (pl)
AU (1)	AU2005242138B2 (pl)
BR (1)	BRPI0506400B8 (pl)
CA (1)	CA2529265C (pl)
CR (1)	CR9267A (pl)
CY (1)	CY1112247T1 (pl)
DE (1)	DE602005026984D1 (pl)
DK (1)	DK1830850T3 (pl)
EE (1)	EE05394B1 (pl)
HK (1)	HK1186125A1 (pl)
HR (1)	HRP20110392T1 (pl)
IL (1)	IL184123A (pl)
LV (1)	LV13469B (pl)
ME (1)	ME01207B (pl)
MY (1)	MY145845A (pl)
NI (1)	NI200700146A (pl)
NO (1)	NO340376B1 (pl)
NZ (1)	NZ555460A (pl)
PA (1)	PA8654801A1 (pl)
PL (1)	PL1830850T3 (pl)
PT (1)	PT1830850E (pl)
RS (1)	RS51730B (pl)
SI (1)	SI1830850T1 (pl)
TR (1)	TR200504892A1 (pl)
TW (1)	TWI404535B (pl)
WO (1)	WO2006067048A1 (pl)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PL222801B1 (pl) *	2002-07-25	2016-09-30	Janssen Pharmaceutica Nv	Pochodne chinoliny, ich zastosowanie, sposób ich wytwarzania oraz kompozycja farmaceutyczna zawierająca je
JO3270B1 (ar) *	2005-06-28	2018-09-16	Janssen Pharmaceutica Nv	مشتقات كوينولين بصفة عوامل مضادة للبكتيريا
JO2752B1 (en) *	2005-06-28	2014-03-15	شركة جانسين فارماسوتيكا ان. في	Quinoline derivatives acting as antibacterial agents
BRPI0613999B8 (pt) *	2005-06-28	2021-05-25	Janssen Pharmaceutica Nv	uso de um composto derivado de quinolina, o referido composto, sua combinação, composição farmacêutica, uso da referida combinação, e produto
JO2683B1 (en) *	2006-12-06	2013-03-03	جانسين فارماسوتيكا ان. في	Quinoline antibacterial derivatives
JO2725B1 (en) *	2006-12-06	2013-09-15	جانسين فارماسوتيكا ان. في	Quinoline antibacterial derivatives
JO2970B1 (en) *	2006-12-06	2016-03-15	جانسين فارماسوتيكا ان. في	Quinoline antibacterial derivatives
JO3271B1 (ar)	2006-12-06	2018-09-16	Janssen Pharmaceutica Nv	مشتقات الكوينولين المضادة للجراثيم
US20110059948A1 (en) *	2008-01-14	2011-03-10	Jyoti Chattopadhyaya	Quinoline, naphthalene and conformationally constrained quinoline or naphthalene derivatives as anti-mycobacterial agents
RU2404971C2 (ru) *	2008-12-02	2010-11-27	ЗАО "Фарм-Синтез"	Новые производные хинолина, способ их получения, их применение для лечения микобактериальных инфекций, фармацевтическая композиция на их основе
US8741917B2 (en)	2009-01-15	2014-06-03	Rutgers, The State University Of New Jersey	Benzo [C] phenanthridines as antimicrobial agents
US20120059026A1 (en)	2009-04-30	2012-03-08	University Of Medicine And Dentistry Of New Jersey	Antimicrobial agents
US8933096B2 (en)	2010-06-09	2015-01-13	Rugers, The State University of New Jersey	Antimicrobial agents
US9102617B2 (en)	2010-06-25	2015-08-11	Rutgers, The State University Of New Jersey	Antimicrobial agents
US9822108B2 (en)	2012-01-13	2017-11-21	Rutgers, The State University Of New Jersey	Antimicrobial agents
WO2013142712A1 (en)	2012-03-21	2013-09-26	Rutgers, The State University Of New Jersey	Antimicrobial agents
EA038350B1 (ru)	2012-04-27	2021-08-12	Янссен Фармацевтика Нв	Антибактериальные хинолиновые производные
ES2576491T3 (es)	2012-04-27	2016-07-07	Janssen Pharmaceutica, N.V.	Derivados de quinolina antibacterianos
US9458150B2 (en)	2013-11-08	2016-10-04	Rutgers, The State University Of New Jersey	Antimicrobial agents
AU2016212116B2 (en)	2015-01-27	2021-07-15	Janssen Pharmaceutica Nv	Dispersible compositions
WO2017147316A1 (en)	2016-02-25	2017-08-31	Taxis Pharmaceuticals, Inc.	Synthetic processes and intermediates
US10508097B2 (en) *	2016-03-07	2019-12-17	The Global Alliance For Tb Drug Development, Inc.	Antibacterial compounds and uses thereof
RU2629369C1 (ru) *	2016-10-05	2017-08-29	Федеральное Государственное Унитарное Предприятие "Государственный Ордена Трудового Красного Знамени Научно-Исследовательский Институт Химических Реактивов И Особо Чистых Химических Веществ"	Четвертичные аммонийные производные 2-аминотиофен-3-карбоксилатов, обладающие противотуберкулезной активностью
CA3058183A1 (en)	2017-03-30	2018-10-04	Taxis Pharmaceuticals, Inc.	Synthetic processes and synthetic intermediates
WO2019012100A1 (en)	2017-07-14	2019-01-17	Janssen Pharmaceutica Nv	EXTENDED ACTION FORMULATIONS
RU2661151C1 (ru) *	2017-12-14	2018-07-12	Федеральное государственное бюджетное образовательное учреждение высшего образования "Московский государственный университет имени М.В. Ломоносова" (МГУ)	Селективные ингибиторы глицеральдегид-3-фосфатдегидрогеназы микобактерий
JP2022516671A (ja)	2019-01-09	2022-03-01	ヤンセンファーマシューティカエヌ．ベー．	非結核性抗酸菌症の処置における組合せ
US20230241051A1 (en)	2020-07-09	2023-08-03	Janssen Pharmaceutica Nv	Long-acting formulations
JP2023532982A (ja)	2020-07-09	2023-08-01	ヤンセンファーマシューティカエヌ．ベー．	長時間作用型配合物
CN116406270A (zh)	2020-11-12	2023-07-07	詹森药业有限公司	在治疗非结核分枝杆菌疾病时的贝达喹啉、乙胺丁醇和大环内酯的组合
WO2023232838A1 (en)	2022-05-31	2023-12-07	Janssen Pharmaceutica Nv	Bedaquiline for use in the treatment of leprosy
WO2024068693A1 (en)	2022-09-28	2024-04-04	Janssen Pharmaceutica Nv	Long-acting formulations
WO2024068699A1 (en)	2022-09-28	2024-04-04	Janssen Pharmaceutica Nv	Long-acting formulations

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AR038536A1 (es) *	2002-02-25	2005-01-19	Upjohn Co	N-aril-2-oxazolidinona-5- carboxamidas y sus derivados
PL222801B1 (pl) *	2002-07-25	2016-09-30	Janssen Pharmaceutica Nv	Pochodne chinoliny, ich zastosowanie, sposób ich wytwarzania oraz kompozycja farmaceutyczna zawierająca je

2005
- 2005-12-05 EE EEP200500033A patent/EE05394B1/xx unknown
- 2005-12-06 CA CA2529265A patent/CA2529265C/en active Active
- 2005-12-07 PA PA20058654801A patent/PA8654801A1/es unknown
- 2005-12-07 MY MYPI20055732A patent/MY145845A/en unknown
- 2005-12-07 AU AU2005242138A patent/AU2005242138B2/en active Active
- 2005-12-08 ME MEP-2011-92A patent/ME01207B/me unknown
- 2005-12-08 TW TW094143290A patent/TWI404535B/zh active
- 2005-12-08 EP EP05815816A patent/EP1830850B1/en active Active
- 2005-12-08 SI SI200531294T patent/SI1830850T1/sl unknown
- 2005-12-08 AP AP2007004054A patent/AP2327A/xx active
- 2005-12-08 CN CN201210507318.XA patent/CN103142595B/zh active Active
- 2005-12-08 BR BRPI0506400A patent/BRPI0506400B8/pt active IP Right Grant
- 2005-12-08 WO PCT/EP2005/056594 patent/WO2006067048A1/en active Application Filing
- 2005-12-08 PT PT05815816T patent/PT1830850E/pt unknown
- 2005-12-08 RS RS20110221A patent/RS51730B/en unknown
- 2005-12-08 AT AT05815816T patent/ATE501721T1/de active
- 2005-12-08 US US11/296,992 patent/US20060142279A1/en not_active Abandoned
- 2005-12-08 NZ NZ555460A patent/NZ555460A/en unknown
- 2005-12-08 DK DK05815816.3T patent/DK1830850T3/da active
- 2005-12-08 PL PL05815816T patent/PL1830850T3/pl unknown
- 2005-12-08 TR TR2005/04892A patent/TR200504892A1/xx unknown
- 2005-12-08 DE DE602005026984T patent/DE602005026984D1/de active Active
- 2005-12-09 AR ARP050105140A patent/AR051790A1/es unknown
- 2005-12-09 LV LVP-05-161A patent/LV13469B/lv unknown
2007
- 2007-06-05 NI NI200700146A patent/NI200700146A/es unknown
- 2007-06-21 IL IL184123A patent/IL184123A/en active IP Right Grant
- 2007-07-20 CR CR9267A patent/CR9267A/es not_active Application Discontinuation
- 2007-07-23 NO NO20073823A patent/NO340376B1/no unknown
2011
- 2011-05-24 HR HR20110392T patent/HRP20110392T1/hr unknown
- 2011-06-15 CY CY20111100563T patent/CY1112247T1/el unknown
2013
- 2013-12-09 HK HK13113666.1A patent/HK1186125A1/xx unknown

Also Published As

Publication number	Publication date
US20060142279A1 (en)	2006-06-29
EE200500033A (et)	2006-08-15
PA8654801A1 (es)	2006-08-03
NO340376B1 (no)	2017-04-10
LV13469B (en)	2007-01-20
TWI404535B (zh)	2013-08-11
EE05394B1 (et)	2011-04-15
BRPI0506400B1 (pt)	2021-04-06
ATE501721T1 (de)	2011-04-15
AP2327A (en)	2011-11-25
NZ555460A (en)	2008-11-28
CN103142595B (zh)	2015-05-06
AU2005242138A1 (en)	2006-07-13
CN103142595A (zh)	2013-06-12
MY145845A (en)	2012-04-30
CA2529265A1 (en)	2006-06-24
ME01207B (me)	2013-03-20
PT1830850E (pt)	2011-05-31
NI200700146A (es)	2019-05-10
CA2529265C (en)	2014-02-11
AU2005242138B2 (en)	2011-05-26
DE602005026984D1 (de)	2011-04-28
BRPI0506400A8 (pt)	2017-09-12
AR051790A1 (es)	2007-02-07
EP1830850A1 (en)	2007-09-12
DK1830850T3 (da)	2011-06-14
TW200637551A (en)	2006-11-01
CY1112247T1 (el)	2015-12-09
EP1830850B1 (en)	2011-03-16
WO2006067048A1 (en)	2006-06-29
RS51730B (en)	2011-10-31
NO20073823L (no)	2007-07-23
TR200504892A1 (tr)	2010-04-21
BRPI0506400A (pt)	2006-08-29
CR9267A (es)	2008-09-09
IL184123A0 (en)	2008-12-29
HRP20110392T1 (hr)	2011-06-30
AP2007004054A0 (en)	2007-06-30
HK1186125A1 (en)	2014-03-07
IL184123A (en)	2011-10-31
SI1830850T1 (sl)	2011-07-29
BRPI0506400B8 (pt)	2021-05-25

Publication	Publication Date	Title
HK1186125A1 (en)	2014-03-07	Quinoline derivatives for the treatment of latent tuberculosis
AP2037A (en)	2009-10-09	Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases
PL1802579T3 (pl)	2014-04-30	Pochodne 3-aryloaminopirydynowe
HK1096083A1 (en)	2007-05-25	Sulfonamide derivatives for the treatment of diseases
AP2006003669A0 (en)	2006-06-30	Sulfonamide derivatives for the treatment of diseases
IL177232A0 (en)	2006-12-10	Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
HK1098155A1 (en)	2007-07-13	Nicotinic receptor agonists for the treatment of inflammatory diseases
HK1104235A1 (en)	2008-01-11	S-mirtazapine for the treatment of hot flush
EP1750698A4 (en)	2010-06-02	5-ANILINO-4-HETEROARYLPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES
ZA200705160B (en)	2008-09-25	Quinoline derivatives for the treatment of latent tuberculosis
ZA200800921B (en)	2009-06-24	Pyrazolone derivatives for the treatment of tuberculosis
ZA200608015B (en)	2008-12-31	Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
GB0408297D0 (en)	2004-05-19	Indole derivatives for the treatment of diseases
GB0412299D0 (en)	2004-07-07	Method for the synthesis of halogenated heterocycles
GB0406387D0 (en)	2004-04-21	Sulfonamide derivatives for the treatment of diseases
GB0406388D0 (en)	2004-04-21	Sulfonamide derivatives for the treatment of diseases
HK1096379A1 (en)	2007-06-01	Sulfonamide derivatives for the treatment of diseases